(Q54323377)

27 May 2018

title

Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time? (English)

1 reference

27 May 2018

1 reference

Wilson Sheridan

1

1 reference

27 May 2018

Tyldesley Scott

2

1 reference

27 May 2018

Speers Caroline

3

1 reference

27 May 2018

Zheng Yvonne

4

1 reference

27 May 2018

Bernstein Vanessa

5

1 reference

27 May 2018

Voduc David

6

1 reference

27 May 2018

Gelmon Karen

7

1 reference

27 May 2018

Chia Stephen

8

1 reference

27 May 2018

language of work or name

English

0 references

publication date

11 September 2014

1 reference

27 May 2018

Breast Cancer Research and Treatment

published in

1 reference

27 May 2018

volume

147

1 reference

27 May 2018

issue

3

1 reference

27 May 2018

page(s)

617-629

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s10549-014-3125-1

exact match

0 references

cites work

Effects of young age at presentation on survival in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Patient and tumor characteristics associated with increased mortality in young women (< or =40 years) with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Breast cancer before age 40 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Improvement in breast cancer outcomes over time: are older women missing out?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Long-term survival expectations of cancer patients in Europe in 2000-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Survival trends in European cancer patients diagnosed from 1988 to 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Obesity and cancer pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3125-1

10.1007/S10549-014-3125-1

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018